| Literature DB >> 23585730 |
Kate Porter1, Sen-Lin Tang, Chung-Pin Chen, Pei-Wen Chiang, Mei-Jhu Hong, Mike Dyall-Smith.
Abstract
Halovirus PH1 infects Haloarcula hispanica and was isolated from an Australian salt lake. The burst size in single-step growth conditions was 50-100 PFU/cell, but cell density did not decrease until well after the rise (4-6 hr p.i.), indicating that the virus could exit without cell lysis. Virions were round, 51 nm in diameter, displayed a layered capsid structure, and were sensitive to chloroform and lowered salt concentration. The genome is linear dsDNA, 28,064 bp in length, with 337 bp terminal repeats and terminal proteins, and could transfect haloarchaeal species belonging to five different genera. The genome is predicted to carry 49 ORFs, including those for structural proteins, several of which were identified by mass spectroscopy. The close similarity of PH1 to SH1 (74% nucleotide identity) allowed a detailed description and analysis of the differences (divergent regions) between the two genomes, including the detection of repeat-mediated deletions. The relationship of SH1-like and pleolipoviruses to previously described genomic loci of virus and plasmid-related elements (ViPREs) of haloarchaea revealed an extensive level of recombination between the known haloviruses. PH1 is a member of the same virus group as SH1 and HHIV-2, and we propose the name halosphaerovirus to accommodate these viruses.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23585730 PMCID: PMC3622292 DOI: 10.1155/2013/456318
Source DB: PubMed Journal: Archaea ISSN: 1472-3646 Impact factor: 3.273
Strains used in this study.
| Species/isolate | Strain | Reference |
|---|---|---|
| CSW 2.09.4 | Original isolate | [ |
|
| ATCC 33960 | [ |
|
| ATCC 43044 | [ |
|
| ATCC 33800 | [ |
|
| NCIMB 763 | [ |
|
| ATCC 33959 | [ |
|
| NCIMB 13854 | [ |
|
| ATCC 33500 | [ |
|
| ATCC 29605 | [ |
|
| ACAM 3911 | [ |
|
| ACAM 34 | [ |
|
| NCIMB 2081 | [ |
|
| NCIMB 784 | [ |
|
| JCM 9576 | [ |
Figure 1Purified PH1 virus examined by negative-stain electron microscopy. Particles were stained with 2% (w/v) uranyl acetate. Scale bar represents 100 nm.
Figure 2Growth curve of PH1. An early exponential culture of Har. hispanica in 18% (w/v) MGM was infected with virus (MOI, 50), washed to remove unbound virus, and incubated at 37°C. At regular intervals, samples were removed, the absorbance at 550 nm were measured (circles), and the number of infectious centres were determined by plaque assay (squares). Error bars represent one standard deviation of the average titre.
Figure 3Stability of PH1 virus to various treatments and conditions. Virus preparations (infected-cell supernatants in 18% (w/v) MGM) were exposed to various conditions, after which the virus titre was determined (in duplicate) on Har. hispanica cells. (a) The effect of temperature. Virus was incubated for 1 hr with constant agitation at temperatures between 4 and 100°C. (b) The effect of lowered salt concentration. Virus was diluted 1 : 1,000 in double-distilled H2O and incubated at room temperature, with constant agitation. Samples were removed at regular intervals. (c) The effect of pH. Virus was diluted 1 : 100 in Tris-HCl buffers at the different pHs and incubated with constant agitation for 30 min. (d) The effect of chloroform. Chloroform was mixed with virus (1 : 4 ratio) and incubated at room temperature with constant agitation. Samples were removed at regular intervals. Open square symbols indicate where virus titres were undetectable. Error bars represent one standard deviation of the average titre.
Figure 4Structural proteins of halovirus PH1. Viral structural proteins were separated by SDS-PAGE on a 12% (w/v) acrylamide gel and stained with Brilliant Blue G (a). They were run in parallel with the proteins of purified SH1 virus (b). The sizes of protein standard markers are indicated on the left side (in kDa). Asterisks denote proteins bands of PH1 that were identified by mass spectroscopy. The numbering of proteins of PH1 (VP1–VP12) follows that of the SH1 homologs seen in (b) (and explained also in the text).
PH1 virus proteins identified by mass spectroscopy of tryptic peptides.
| Proteina | Locus tag | ORF | MW (kDa) | Matching peptide massesb |
|---|---|---|---|---|
| Observed (calculated) | ||||
| VP1 | HhPH1_gp12 | 12 | 185 (158) | 16 |
| VP2 | HhPH1_gp24 | 24 | 100 (78) | 15 |
| VP3 | HhPH1_gp28 | 28 | 40 (38) | 5 |
| VP4 | HhPH1_gp21 | 21 | 35 (26) | 5 |
| VP7 | HhPH1_gp20 | 20 | 24 (20) | 5 |
| VP9 | HhPH1_gp27 | 27 | 16 (17) | 3 |
| VP10 | HhPH1_gp26 | 26 | 15 (17) | 4 |
| VP12 | HhPH1_gp19 | 19 | 7 (9.9) | 4 |
aVirus capsid proteins are numbered according to their similarity with SH1 capsid proteins.
bThe number of peptide masses between 750.0 and 3,513.0 m/z identified by MALDI-TOF MS that correspond to the theoretical tryptic peptides of the predicted virus protein.
Digestion of the PH1 genome by nucleasesa.
| Nuclease (amount) | Proteinase K-treated | Untreated | ||
|---|---|---|---|---|
| Control | PH1 DNA | Control | PH1 DNA | |
| DNase I (RNase-free) | +b | + | +b | + |
| Exonuclease III | +b | + | +b | + |
| Mung bean nuclease | +c | − | +c | − |
| Nuclease BAL-31 | +b | + | +b | − |
| RNase A | +d | − | +d | − |
| T7 exonuclease | +b | + | +b | − |
aExtracted nucleic acid from purified PH1 virus was treated with various nucleases and then analysed by gel electrophoresis to detect whether the nuclease digested (+) or did not digest (−) the genome. Control nucleic acids used to confirm activity of the nucleases were b λ DNA, ca DNA oligonucleotide, and dyeast transfer RNA.
Figure 5Detection of proteins bound to the termini of PH1 DNA. DNA was extracted from purified PH1 particles without proteinase K, digested with AseI, then passed through a silica filter (GF/C) under conditions where proteins would bind to the filter. Lane 1: AseI fragments that did not bind and were eluted. Lane 2: AseI fragments that bound and were eluted only after protease treatment. Lane 3: AseI digest of PH1 DNA. The positions of DNA size standards are indicated on the left side, in kb. The calculated sizes of the AseI fragments of PH1 DNA in lane 3 are indicated on the right side (also in kb). The predicted 0.62 kb PH1 AseI fragment was not detected.
ORF annotations of the halovirus PH1 genome.
| ORFa | Positionb | Locus tag | Lengthc (aa) | pKi | Similarity/characteristics |
|---|---|---|---|---|---|
| 1 | 441–605 | HhPH1_gp01 | 50 | 4.3 | 76% aa similarity to SH1 ORF2 (YP_271859) |
| 2 | 602–802 | HhPH1_gp02 | 66 | 10.9 | 80% aa similarity to SH1 ORF3 (YP_271860) |
| 3 | 802–1059 | HhPH1_gp03 | 85 | 3.9 | 85% aa similarity to SH1 ORF4 (YP_271861). 44% similarity to HHIV-2 protein 1 |
| 4 | 1056–1283 | HhPH1_gp04 | 75 | 3.9 | 85% aa identity to SH1 ORF5 (YP_271862). Predicted coiled-coil region. |
| 5 | 1276–1686 | HhPH1_gp05 | 136 | 4.9 | 80% aa similarity to SH1 ORF6 (YP_271863). Two transmembrane domains. Also related to HHIV-2 protein 2 (38%, AFD02283) and to |
| 6 | 1683–1829 | HhPH1_gp06 | 48 | 6.1 | 81% aa similarity to SH1 ORF7 (YP_271864). Predicted signal sequence (SignalP). |
| 7 | 1822–2130 | HhPH1_gp07 | 102 | 5.8 | 91% aa similarity to SH1 ORF8 (YP_271865) and 86% to HHIV-2 putative protein 3 (AFD02284). Other homologs include |
| 8 | 2123–2383 | HhPH1_gp08 | 86 | 4.2 | 90% aa similarity to SH1 ORF9 (YP_271866) |
| 9 | 2380–2714 | HhPH1_gp09 | 111 | 5.2 | 88% aa similarity to SH1 ORF11 (YP_271868) and also similarity to putative protein 4 of HHIV-2 (AFD02285) HlacAJ_19877 of |
| 10 | 2861–3004 | HhPH1_gp10 | 47 | 10.4 | Weak similarity to SH1 ORF12 (YP_271869) only over the N-terminal 18 residues |
| 11 | 3029–3100 | HhPH1_gp11 | 23 | 12.3 | Not present in SH1 or HHIV-2 |
| 12 | 3134–7453 | HhPH1_gp12 | 1439 | 4.2 |
|
| 13 | 7505–8227 | HhPH1_gp13 | 240 | 5.4 |
|
| 14 | 8419–8228c | HhPH1_gp14 | 63 | 5.1 | 43% aa similarity to SH1 ORF18 (YP_271875). Alanine-rich. Central transmembrane domain (Phobius) |
| 15 | 8856–8416c | HhPH1_gp15 | 146 | 4.1 | 92% aa similarity to SH1 ORF19 (YP_271876) and also to HHIV-2 putative protein 9 (AFD02290); HlacAJ_19857 of |
| 16 | 8853–9500c | HhPH1_gp16 | 215 | 3.9 | 65% aa similarity to SH1 ORF20 (YP_271877) and also to putative protein 11 of HHIV-2 (AFD02292); ZOD2009_19098 of |
| 17 | 9500–9919c | HhPH1_gp17 | 139 | 4.1 | 79% aa similarity to SH1 ORF21 (YP_271878) and also to putative protein 12 of HHIV-2 (AFD02293); hypothetical protein HlacAJ_19847 of |
| 18 | 9923–10594c | HhPH1_gp18 | 223 | 4.3 | 83% aa similarity to SH1 ORF22 (YP_271879) and also to putative protein 13 of HHIV-2 (AFD02294), ZOD2009_19108 of |
| 19 | 10659–10943 | HhPH1_gp19 | 94 | 10.4 |
|
| 20 | 10960–11517 | HhPH1_gp20 | 185 | 4.4 |
|
| 21 | 11519–12217 | HhPH1_gp21 | 232 | 4.1 |
|
| 22 | 12233–12454 | HhPH1_gp22 | 73 | 3.9 | 81% aa similarity to SH1 ORF26 (YP_271883) and also to putative protein 17 of HHIV-2 (AFD02298); |
| 23 | 12458–12697 | HhPH1_gp23 | 79 | 4.8 | 78% aa similarity to SH1 |
| 24 | 12701–15064 | HhPH1_gp24 | 787 | 3.9 |
|
| 25 | 15065–15961 | HhPH1_gp25 | 298 | 4.5 |
|
| 26 | 15964–16446 | HhPH1_gp26 | 160 | 4.6 | 73% aa similarity to SH1 |
| 27 | 16446–16895 | HhPH1_gp27 | 149 | 4.2 |
|
| 28 | 16908–17921 | HhPH1_gp28 | 337 | 4.3 |
|
| 29 | 17928–18617 | HhPH1_gp29 | 229 | 4.2 |
|
| 30 | 18614–18943 | HhPH1_gp30 | 109 | 4.9 | 71% aa similarity to SH1 ORF34 (YP_271891) and to putative protein 27 of HHIV-2 (AFD02308); Predicted signal sequence (signalP) |
| 31 | 19054–19176c | HhPH1_gp31 | 40 | 5.0 | Two CxxC motifs. No homolog in SH1 or HHIV-2 |
| 32 | 19173–19289c | HhPH1_gp32 | 38 | 4.1 | 68% aa similarity to SH1 ORF37 (YP_271894) |
| 33 | 19286–19552c | HhPH1_gp33 | 88 | 5.3 | 58% aa similarity to SH1 ORF39 (YP_271896) and to HHIV-2 putative protein 29 (AFD02310). Four CxxC motifs |
| 34 | 19549–19731c | HhPH1_gp34 | 60 | 7.0 | Contains CxxC motif. No homolog in SH1 or HHIV-2 |
| 35 | 19728–20219c | HhPH1_gp35 | 163 | 5.6 | 93% aa similarity to SH1 ORF 41 (YP_271898) and to putative protein 30 of HHIV-2 (AFD02311) |
| 36 | 20216–21415c | HhPH1_gp36 | 399 | 5.0 | 95% aa similarity to SH1 ORF 42 (YP_271899) and to putative protein 31 of HHIV-2 (AFD02312) |
| 37 | 21419–21778c | HhPH1_gp37 | 119 | 4.1 | 91% aa similarity to SH1 ORF43 (YP_271900) and to putative protein 32 of HHIV-2 (AFD02313) |
| 38 | 21762–23006c | HhPH1_gp38 | 414 | 4.2 | 83% aa similarity to SH1 ORF44 (YP_271901) and to putative protein 33 of HHIV-2 (AFD02314). Predicted coil-coil and helix-turn-helix domains |
| 39 | 23003–23158c | HhPH1_gp39 | 51 | 6.5 | 69% aa similarity to SH1 ORF45 (YP_271902) |
| 40 | 23161–23370c | HhPH1_gp40 | 69 | 3.5 | 74% aa similarity to SH1 ORF46 (YP_271903), and 55% similarity to putative protein 35 of HHIV-2 (AFD02316) |
| 41 | 23422–23586c | HhPH1_gp41 | 54 | 7.6 | 86% aa similarity to SH1 ORF47 (YP_271904); Contains 2 CxxC motifs, and shows similarity to protein domain family PF14206. Arginine-rich |
| 42 | 23583–24023c | HhPH1_gp42 | 4.8 | 77% aa similarity to SH1 ORF48 (YP_271905) and to putative protein 36 of HHIV-2 (AFD02317); Hham1_14540 of | |
| 43 | 24020–24538c | HhPH1_gp43 | 172 | 4.7 | 79% aa similarity to SH1 ORF49 (YP_271906), and 56% similarity to putative protein 37 of HHIV-2 (AFD02318) |
| 44 | 24535–25053c | HhPH1_gp44 | 172 | 4.3 | 92% aa similarity to SH1 ORF50 (YP_271907), and 72% similarity to putative protein 38 of HHIV-2 (AFD02319) |
| 45 | 25050–25277c | HhPH1_gp45 | 75 | 4.3 | No homolog in SH1 or HHIV-2. |
| 46 | 25274–25387c | HhPH1_gp46 | 37 | 4.8 | No homolog in SH1 or HHIV-2 |
| 47 | 25533–25904 | HhPH1_gp47 | 123 | 4.3 | 61% aa similarity to SH1 ORF51 (YP_271908); 66% similarity to putative protein 39 of HHIV-2 (AFD02320). Predicted COG1342 domain (DNA binding/helix-turn-helix) |
| 48 | 25901–26092c | HhPH1_gp48 | 63 | 4.9 | Contains CxxC motif. No homolog in SH1 or HHIV-2 |
| 49 | 26089–27648c | HhPH1_gp49 | 506 | 4.0 | 81% aa similarity to SH1 ORF55 (YP_271912) (but only in the N-terminal half). Homolog of |
aORFs were predicted either by GLIMMER or by manual searching for homologs in the GenBank database.
bStart and end positions of ORFs are give in bp number according to the PH1 sequence deposited at GenBank (KC252997). ORFs on the complementary strand are denoted by the suffix c.
cLength of the predicted ORF, in number of amino acids.
Figure 6Genome alignments of haloviruses PH1, SH1, and HHIV-2, along with two related genomic loci. (a) Genomic loci of Hap. paucihalophilus and Hbf. lacisalsi that contain genes related to halosphaeroviruses SH1, PH1, and HHIV-2. The names and GenBank accessions for these contigs are given on the far right, and ORFs are coloured and labeled to indicate the relationships of these ORFs to those of the viruses below. The locus tag numbers for the first and last ORFs shown in each locus are given nearby their respective ORFs. In addition, grey coloured ORFs represent sequences that do not match any of the haloviruses, and green coloured ORFs represent protein sequences that are closely related to ORFs found within or very close to previously described virus/plasmid loci, so called ViPREs [20]. The scale bars shown above each contig show the position of the described region within the respective contig. (b) The three virus genomes are labeled at the left, with scale markers below (in kb) and the total length indicated at the far right. At the bottom is a cumulative AT-skew plot of the PH1 genome (http://molbiol-tools.ca/Jie_Zheng/), with inflection points circled. The grey shaded bands between the genome diagrams indicate significant nucleotide similarity (using ACT [63]). Annotated ORFs are represented by arrows, with colours indicating structural proteins (red or brown), nonstructural proteins (yellow or orange) or the packaging ATPase (blue). The names of structural protein ORFs are indicated either within the arrow (e.g., VP1) or in text nearby. The numbered, orange coloured ORFs of HHIV-2 are homologous to ORFs found in the genomic loci (probably proviruses or provirus remnants) pictured in (a).
Main differences (divergent regions) between the SH1 and PH1 genomes.
| Regiona | SH1 startb | SH1 stop | Length (bp) | PH1 start | PH1 stop | Length (bp) | Comment |
|---|---|---|---|---|---|---|---|
| DV1 | 527 | 650 | 123 | 538 | 604 | 66 | Replacement. Both regions have direct repeats at their borders; PH1 has two sets GACCCGGC and CGCTGC, while SH1 has CCCGAC. In SH1, this replacement region includes the C-terminal region of ORF2 and the N-terminal region of ORF3. In PH1, it covers only the C-terminal region of ORF1 |
|
| |||||||
| DV2 | 2433 | 2588 | 155 | 2386 | 2387 | — | RMDc from PH1. SH1 repeat at border is TGACCG. This removes the homolog of SH1 ORF10 from PH1 |
|
| |||||||
| DV3 | 3324 | 3598 | 274 | 3137 | 3416 | 279 | Replacement at the beginning of SH1 ORF13/PH1 ORF12 (capsid protein VP1) |
|
| |||||||
| DV4 | 6656 | 7128 | 472 | 6478 | 7085 | 607 | Replacement near the C-terminus of SH1 ORF13/PH1 ORF12 (capsid protein VP1) |
|
| |||||||
| DV5 | 7491 | 8341 | 850 | 7446 | 7447 | — | Indel that results in ORFs14-16 of SH1 not being present in PH1. SH1 ORF14 has a close homolog in HHIV-2 (ORF6), in a similar position, just after the VP1 homolog. SH1 ORF15 is a conserved protein in haloarchaea (e.g. NP_2552A, and Hmuk_2978) and halovirus His1 (ORF13). Possible inverted repeat (AGCCATG) at border of SH1 region |
|
| |||||||
| DV6 | 13705 | 13706 | — | 12818 | 12851 | 33 | RMD from SH1. PH1 repeat at border is CAGCGG(g/t)G. This removes a part of capsid protein VP2 sequence from the SH1 protein |
|
| |||||||
| DV7 | 13789 | 13863 | 74 | 12934 | 12941 | 7 | Replacement. This occurs within VP2 gene of both viruses |
|
| |||||||
| DV8 | 15142 | 15186 | 44 | 14220 | 14221 | — | RMD from PH1. SH1 repeat at border is TG(t/c)CCGACGA and occurs within capsid protein VP2 gene of both viruses |
|
| |||||||
| DV9 | 15303 | 15317 | 14 | 14337 | 14338 | — | RMD from PH1. SH1 repeat at border is GCCGACGA and occurs within capsid protein VP2 gene of both viruses |
|
| |||||||
| DV10 | 15504 | 15527 | 23 | 14529 | 14530 | — | RMD from PH1. SH1 repeat at border is GACGA and occurs within capsid protein VP2 of both viruses |
|
| |||||||
| DV11 | 20026 | 20405 | 379 | 19019 | 19173 | 154 | Replacement beginning at the start of SH1 ORF35/PH1 ORF31. This region is longer in SH1, where it includes ORF36, an ORF that has no homolog present in PH1 |
|
| |||||||
| DV12 | 20440 | 20661 | 221 | 19208 | 19286 | 78 | Replacement. This is unequal and includes an ORF in SH1 (ORF38) that is not present in PH1 |
|
| |||||||
| DV13 | 20943 | 21085 | 142 | 19562 | 19728 | 166 | Replacement. This covers SH1 ORF40/PH1 ORF34. The predicted proteins are not homologous |
|
| |||||||
| DV14 | 23541 | 23542 | — | 22171 | 22197 | 27 | Probable RMD in SH1. PH1 repeat at border is CGTCTCGG and occurs in SH1 ORF44/PH1 ORF38 |
|
| |||||||
| DV15 | 24506 | 24521 | 15 | 23152 | 23153 | — | Probable RMD in PH1. SH1 repeat at border is CTCGGT and occurs near the end of SH1 ORF45/PH1 ORF39 |
|
| |||||||
| DV16 | 24951 | 24964 | 13 | 23579 | 23580 | — | Probable RMD in PH1. SH1 repeat at border is CGGTC and occurs in SH1 ORF47/PH1 ORF41 |
|
| |||||||
| DV17 | 26449 | 26450 | — | 25050 | 25274 | 224 | Probable RMD in SH1. PH1 repeat at border is TCATGCG and occurs near the start of SH1 ORF50/PH1 ORF44 and provides an extra ORF for PH1 (ORF45) |
|
| |||||||
| DV18 | 27074 | 29764 | 690 | 25895 | 26933 | 1038 | Replacement. Left border at start of SH1 ORF51/PH1 ORF47 and extends rightwards into SH1 ORF55/PH1 ORF49 (VP18 gene). It is an unequal replacement and SH1 has two more ORFs in this region than PH1 |
aDV: Divergent regions between the genomes of SH1 and PH1.
bStart and stop positions refer to the GenBank sequences of the two viruses: SH1, NC_007217.1; PH1, KC252997.
cRMD: repeat-mediated deletion event, as described in [20].
Figure 7Transfection of Har. hispanica cells with PH1 DNA. Varying amounts of nonproteinase K-treated PH1 DNA were introduced into cells of Har. hispanica using the PEG method [64]. Cells were then screened for infective centres by plaque assay. Data shown is the average of three independent experiments, performed in duplicate. Error bars represent one standard deviation of the mean. If protease-treated DNA was used, no transfectant plaques were observed.
Transfection of haloarchaea by PH1 DNA.
| Speciesa | Efficiency of transfection/transformation with | |
|---|---|---|
| PH1 DNAb (PFU/ | pUBP2 DNAb,c (CFU/ | |
|
| 5.3 ± 0.5 × 103 | 1.4 ± 0.8 × 104 |
|
| 4.5 ± 0.7 × 103 | 1.8 ± 0.1 × 104 |
|
| 3.2 ± 0.6 × 102 | — |
|
| — | 5.4 ± 4.2 × 103 |
|
| 2.8 ± 0.8 × 103 | 4.0 ± 2.6 × 103 |
|
| — | 5.7 ± 1.1 × 103 |
|
| — | 2.1 ± 0.7 × 105 |
|
| 7.0 ± 2.2 × 102 | 9.5 ± 1.5 × 103 |
|
| 1.6 ± 1.7 × 102 | 2.4 ± 0.6 × 103 |
|
| 3.5 ± 3.9 × 102 | 3.1 ± 1.0 × 104 |
aOnly those species positive for transfection and/or plasmid transformation are shown.
bRates of transfection by (nonprotease treated) PH1 DNA or transformation by plasmid pUB2 are averages of three independent experiments, each performed in duplicate (± standard deviation).
cTransformants were selected on plates with 2, 4, or 6 μg/mL simvastatin, depending on the strain.
— no plaques or colonies observed.